Severe Acute Respiratory Syndrome Coronavirus-2 Pneumonia in a Newborn Treated With Remdesivir and Coronavirus Disease 2019 Convalescent Plasma
Andrew J. Hopwood, Alejandro Jordán-Villegas, Liliana D Gutierrez, Mallory C. Cowart, Wilfredo Vega-Montalvo, Wang Leung Cheung, Michael McMahan, Michael R. Gomez, Federico R. Laham
Abstract
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is a novel pandemic virus. Mounting evidence supports the possibility of vertical transmission, which at the present time appears to be rare. We report a newborn with vertically acquired SARS-CoV-2 who developed acute respiratory failure and received remdesivir and coronavirus disease 2019 convalescent plasma.
Topics & Concepts
MedicineCoronavirusPneumoniaPandemicCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Convalescent plasmaRespiratory systemVirologyBetacoronavirusTransmission (telecommunications)2019-20 coronavirus outbreakDiseaseSevere acute respiratory syndrome coronavirusViral pneumoniaIntensive care medicineInternal medicineInfectious disease (medical specialty)OutbreakEngineeringElectrical engineeringCOVID-19 Impact on ReproductionCOVID-19 Clinical Research StudiesNeonatal Health and Biochemistry